Lumiliximab (Anti-FceR2 / CD23)
Lumiliximab (Anti-FceR2 / CD23) is a monoclonal antibody targeting CD23, that inhibits allergen-induced responses. MW: 145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2501 |
| Sku # | A2501-1mg*5 |
| Pricing | 1mg*5, $790.00 |